BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25421114)

  • 1. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [X-linked thrombocytopenia with thalassemia in two families in Sweden. Consider hereditary causes of thrombocytopenia and bone marrow fibrosis].
    Danielsson S; Merup M; Olsson L; Palmblad J; Aström M
    Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1474-7. PubMed ID: 22993897
    [No Abstract]   [Full Text] [Related]  

  • 3. First reported co-occurrence of "GATA1-mutated X-linked thrombocytopenia with thalassemia (XLTT)" with heterozygous β-thalassemia.
    Singh N; Bhatia P; Jamwal M; Khadwal AR; Chhabra S; Hira JK; Das R; Sharma P
    Int J Lab Hematol; 2023 Dec; 45(6):999-1002. PubMed ID: 37382348
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet proteome and function in X-linked thrombocytopenia with thalassemia and
    Bergemalm D; Ramström S; Kardeby C; Hultenby K; Eremo AG; Sihlbom C; Bergström J; Palmblad J; Åström M
    Haematologica; 2021 Nov; 106(11):2947-2959. PubMed ID: 33054111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
    Gianelli U; Fiori S; Cattaneo D; Bossi A; Cortinovis I; Bonometti A; Ercoli G; Bucelli C; Orofino N; Bulfamante G; Iurlo A
    Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
    Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
    Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril mitigates splenomegaly and myelofibrosis in the Gata1
    Corey SJ; Jha J; McCart EA; Rittase WB; George J; Mattapallil JJ; Mehta H; Ognoon M; Bylicky MA; Summers TA; Day RM
    J Cell Mol Med; 2018 Sep; 22(9):4274-4282. PubMed ID: 29971909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
    Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
    Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
    Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
    J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.
    Barosi G
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):129-40. PubMed ID: 25189724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
    Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
    Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability of immunomorphometric assessment of angiogenesis to distinguish primary versus secondary myelofibrosis.
    Sharma P; Pati HP; Mishra PC; Dinda AK; Gupta R; Sharma A; Jacob TG
    Anal Quant Cytol Histol; 2011 Aug; 33(4):236-44. PubMed ID: 21980629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
    Marcinek J; Plank L; Szépe P; Balhárek T
    Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
    Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
    Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.